Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group - Opal, SM; Fisher, CJ, jr.; Dhainaut, JF (Crit Care Med, 1997)
et al.